Lori Taylor

Company: Annexon Biosciences

Job title: Senior VP, Portfolio Strategy & Operations

Seminars:

Upstream vs. Downstream Targeting in GA & AMD 1:30 pm

Discussing the advantages and disadvantages of different complement targets through an ophthalmology lens Delivering complement inhibitors to the eye: topical, intravitreal, or systemic? Future considerations for combination therapies to target multiple complement components in the eyeRead more

day: Conference Day Two

Panel Discussion: Upstream, Downstream or Proximal – Where, When, & How to Target? 11:45 am

Discussing acute versus chronic inflammatory disorders and which proteins within the cascade we can target Understanding disease progression and debating systemic or tissue specific targeting Can combination therapies bridge the gaps and ensure efficacy for treatment?Read more

day: Conference Day One

GBS vs. GA: Treating Both Acute & Chronic Diseases with C1q Inhibition 12:30 pm

Discussing the efficacy of ANX005 in treating Guillain-Barre Syndrome Optimizing dosage for acute and chronic indications Summarizing the differences in the challenges of complement inhibition in acute and chronic indicationsRead more

day: Conference Day One